BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36394179)

  • 1. Targeting Theranostics of Atherosclerosis by Dual-Responsive Nanoplatform via Photoacoustic Imaging and Three-In-One Integrated Lipid Management.
    Ma B; Xiao Y; Lv Q; Li G; Wang Y; Fu G
    Adv Mater; 2023 Feb; 35(5):e2206129. PubMed ID: 36394179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Nanoplatform for Atherosclerosis Inhibition and Degradation via a Dual-Track Reverse Cholesterol Transport Strategy.
    Chen Z; Zhu Q; Li D; Lv Q; Fu G; Ma B; Zhang W
    Small; 2024 Feb; 20(7):e2306457. PubMed ID: 37803917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy.
    Xu H; She P; Zhao Z; Ma B; Li G; Wang Y
    Adv Mater; 2023 May; 35(21):e2300439. PubMed ID: 36828777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aiming at early-stage vulnerable plaques: A nanoplatform with dual-mode imaging and lipid-inflammation integrated regulation for atherosclerotic theranostics.
    Wang Y; Chen Z; Zhu Q; Chen Z; Fu G; Ma B; Zhang W
    Bioact Mater; 2024 Jul; 37():94-105. PubMed ID: 38523705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine accelerates atherosclerosis via inhibiting LXRα-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages.
    Jin P; Bian Y; Wang K; Cong G; Yan R; Sha Y; Ma X; Zhou J; Yuan Z; Jia S
    Life Sci; 2018 Dec; 214():41-50. PubMed ID: 30393020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species-responsive nano-platform with dual-targeting and fluorescent lipid-specific imaging capabilities for the management of atherosclerotic plaques.
    He Z; Chen Q; Duan X; Zhong Y; Zhu L; Mou N; Yang X; Cao Y; Han Z; He H; Wu S; Wang G; Qin X; Qu K; Zhang K; Liu J; Wu W
    Acta Biomater; 2024 Jun; 181():375-390. PubMed ID: 38734284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS Responsive Nanoplatform with Two-Photon AIE Imaging for Atherosclerosis Diagnosis and "Two-Pronged" Therapy.
    Ma B; Xu H; Zhuang W; Wang Y; Li G; Wang Y
    Small; 2020 Nov; 16(45):e2003253. PubMed ID: 33078569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.
    Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages.
    Gabunia K; Ellison S; Kelemen S; Kako F; Cornwell WD; Rogers TJ; Datta PK; Ouimet M; Moore KJ; Autieri MV
    Am J Pathol; 2016 May; 186(5):1361-74. PubMed ID: 26952642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Ultrasound-Responsive Theranostic Cyclodextrin-Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis.
    Mehta S; Bongcaron V; Nguyen TK; Jirwanka Y; Maluenda A; Walsh APG; Palasubramaniam J; Hulett MD; Srivastava R; Bobik A; Wang X; Peter K
    Small; 2022 Aug; 18(31):e2200967. PubMed ID: 35710979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
    Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet.
    Krishna SM; Moxon JV; Jose RJ; Li J; Sahebkar A; Jaafari MR; Hatamipour M; Liu D; Golledge J
    J Cell Physiol; 2018 Oct; 233(10):6951-6964. PubMed ID: 29741759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
    Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
    Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of lipid-rich aortic plaques by intravascular photoacoustic tomography: ex vivo and in vivo validation in a rabbit atherosclerosis model with histologic correlation.
    Zhang J; Yang S; Ji X; Zhou Q; Xing D
    J Am Coll Cardiol; 2014 Jul; 64(4):385-90. PubMed ID: 25060374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Candidate for Prevention and Treatment of Atherosclerosis: Urolithin B Decreases Lipid Plaque Deposition in apoE
    Zhao W; Wang L; Haller V; Ritsch A
    Mol Nutr Food Res; 2019 May; 63(10):e1800887. PubMed ID: 30762936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
    Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
    Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis.
    Wang Y; Gao H; Huang X; Chen Z; Kang P; Zhou Y; Qin D; Zhang W; Liu J
    Carbohydr Polym; 2022 Sep; 292():119632. PubMed ID: 35725197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.